Bicara Therapeutics Inc

BCAXNASDAQ · US

Holders

ACQUIREDStale
Cohlhepp Ryan
Bicara Therapeutics Inc · NASDAQ
+17,500 sh · $66.3K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Cohlhepp Ryan
Bicara Therapeutics Inc · NASDAQ
−14,058 sh · $320.1K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Cohlhepp Ryan
Bicara Therapeutics Inc · NASDAQ
−3,442 sh · $80.7K
Filed 10 Sept 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Bicara Therapeutics Inc · NASDAQ
89,881 sh · $1.8M
Filed 31 Mar 2026SEC 13Fview source